GVR Report cover Hepatitis Diagnostic Test Market Size, Share & Trends Report

Hepatitis Diagnostic Test Market Size, Share & Trends Analysis Report, By Diagnostic Tests (Liver Function, Immunoassays & Nucleic Acid Assays, Imaging, Liver Biopsy), And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-2-68038-369-0
  • Number of Pages: 90
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2015
  • Industry: Healthcare

Report Overview

The global hepatitis diagnostic test market size was valued at USD 3.9 billion in 2016 and is expected to grow at a CAGR of 6.5% over the forecast period. Rising prevalence of hepatitis diagnostics is primarily driving the growth of the global market.

U.S. hepatitis diagnostics market size

Data published by the World Health Organization (WHO) states that hepatitis is the main reason for liver cancer which accounts for approximately 80% of all the liver cancer cases reported worldwide and around 1.4 million deaths annually. Additionally, the report states that around 300 chronic cases are registered globally. Considering, high prevalence of the disease driving the demand for advanced diagnostic tools.

Increasing awareness regarding the disease and its symptoms is creating the demand for the detection of Hepatitis. In addition, constantly rising awareness regarding commercially available advanced products is fueling market growth.  

The paradigm shift from conventional tools to molecular diagnosis has increased the efficiency of procedures and also has lowered the turnaround time. Molecular diagnostics involves genetic tests to confirm the exact strain of the causative virus. The nucleic acid assays used include HCV RNA and HBV DNA analysis tests. Hence, the availability of such advanced detection techniques is spurring the overall market growth.

Test Type Insights

The dominance of the blood tests segment is attributed to the large test volume as they are the 1st line detection tests for hepatitis diagnostics. However, imaging tests are performed as supportive detection tests for the confirmation of liver inflammation. Whereas, in chronic conditions, liver biopsies are performed in order to confirm the exact viral strain. Biopsies are also known to aid the detection of cancerous cells in liver post hepatitis infection.

Liver function tests are the first line detection for liver diseases which is expected to drive the growth of the segment significantly over the forecast period. Liver function tests are expected to dominate the blood tests market throughout the forecast period.

Global hepatitis diagnostics market share

In addition, immunoassays are used to detect the presence of a specific virus in the sample with the help of antibodies and antigens. Furthermore, techniques such as RIBA, PCR system, ELISA, and CLIA are used to perform immunoassays that are not affordable to all patients across the globe. 

Regional Insights

North America dominated the market with the largest revenue share in 2016. Availability of advanced diagnostic tools and high awareness regarding these products are the key factors driving the growth of the market in North America.

The accelerated growth in the Canadian market can be attributed to the initiatives of the government and non-government organizations. For instance, The Public Health Agency of Canada organized the World Hepatitis Day in order to increase awareness regarding hepatitis detection. Thereby, leading to a demand surge for hepatitis detection in the country.

The global Hepatitis report by the WHO states that the prevalence of Type B of the disease in South East Asia is approximately 0.7%. It also states that the incidence rate of HCV infection in 1,000,000 people is 14.7. The WHO also states a few reasons such as unprotected sex, the vital spread of infections, and transfer for body fluids from infected individuals are expected to increase the burden of the disease in the Asia Pacific region. Consequently, the demand for detection techniques is anticipated to grow significantly in Asia Pacific in the near future.

Hepatitis Diagnostic Market Share Insights

The key players of the market include Siemens Ag, F. Hoffmann La-Roche, Abbott Laboratories; DiaSorin S.p.A; bioMeriuex, MedMira, Inc.; Hologic, Inc.; Danaher Corporation, and Bio-Rad Laboratories, etc. Strategies such as mergers and acquisitions, partnerships with small/local players are widely adopted by key players to sustain the competition.

Hepatitis Diagnostic Test Market Report Scope

Report Attribute


Market size value in 2020

USD 5.0 billion

Revenue forecast in 2025

USD 6.9 billion

Growth Rate

CAGR of 6.5% from 2017 to 2025

Base year for estimation


Historical data

2014 - 2016

Forecast period

2017 - 2025

Quantitative units

Revenue in USD Billion and CAGR from 2017 to 2025

Report coverage

Revenue forecast; company share; competitive landscape; growth factors and trends

Segments covered

Test type, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; China; Japan; Brazil; Mexico; & South Africa

Key companies profiled

Siemens Healthineers; F. Hoffmann La-Roche; Abbott Laboratories; DiaSorin S.p.A; bioMeriuex; MedMira; Inc.; Hologic; Inc.; Danaher Corporation; Bio-Rad Laboratories.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country; regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the hepatitis diagnostics market report on the basis of test types and region:

  • Diagnostic Tests Outlook (Revenue, USD Million; 2014 - 2025)

    • Blood tests

      • Liver function tests

      • Immunoassays

      • Nucleic Acid Tests

    • Imaging Tests

    • Liver Biopsy

  • Regional Outlook (Revenue, USD Million; 2014 - 2025)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • The U.K.

    • Asia Pacific

      • China

      • Japan

    • Latin America

      • Mexico

      • Brazil

    • MEA

      • South Africa

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.